CS195714B2 - Method of producing antimicrobially active derivatives of amoniglycoside - Google Patents

Method of producing antimicrobially active derivatives of amoniglycoside Download PDF

Info

Publication number
CS195714B2
CS195714B2 CS771278A CS127877A CS195714B2 CS 195714 B2 CS195714 B2 CS 195714B2 CS 771278 A CS771278 A CS 771278A CS 127877 A CS127877 A CS 127877A CS 195714 B2 CS195714 B2 CS 195714B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
group
amino
protected
Prior art date
Application number
CS771278A
Other languages
Czech (cs)
English (en)
Inventor
Barry C Ross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS195714B2 publication Critical patent/CS195714B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CS771278A 1976-02-25 1977-02-25 Method of producing antimicrobially active derivatives of amoniglycoside CS195714B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7529/76A GB1529243A (en) 1976-02-25 1976-02-25 Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Publications (1)

Publication Number Publication Date
CS195714B2 true CS195714B2 (en) 1980-02-29

Family

ID=9834870

Family Applications (2)

Application Number Title Priority Date Filing Date
CS777810A CS195715B2 (en) 1976-02-25 1977-02-25 Method of producing cyclic urethans
CS771278A CS195714B2 (en) 1976-02-25 1977-02-25 Method of producing antimicrobially active derivatives of amoniglycoside

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS777810A CS195715B2 (en) 1976-02-25 1977-02-25 Method of producing cyclic urethans

Country Status (26)

Country Link
US (1) US4107435A (el)
JP (1) JPS52111545A (el)
AR (1) AR215616A1 (el)
AT (1) AT348123B (el)
BE (1) BE851777A (el)
CA (1) CA1071624A (el)
CH (1) CH618706A5 (el)
CS (2) CS195715B2 (el)
DD (2) DD130150A5 (el)
DE (1) DE2708008C3 (el)
DK (1) DK82177A (el)
EG (1) EG12650A (el)
ES (1) ES456304A1 (el)
FI (1) FI770568A (el)
FR (2) FR2351109A1 (el)
GB (1) GB1529243A (el)
GR (1) GR66424B (el)
HU (1) HU179565B (el)
IE (1) IE44885B1 (el)
LU (1) LU76829A1 (el)
NL (2) NL166265C (el)
PL (2) PL102193B1 (el)
PT (1) PT66229B (el)
RO (1) RO76081A (el)
SE (1) SE7702066L (el)
SU (1) SU659092A3 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461151A (en) * 1977-10-25 1979-05-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
JPS5538345A (en) * 1978-09-11 1980-03-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4226980A (en) * 1978-12-07 1980-10-07 Abbott Laboratories Novel derivatives of fortimicin B and process for preparing same
DE2924659A1 (de) * 1979-06-19 1981-01-22 Bayer Ag Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel
DE3000841A1 (de) * 1980-01-11 1981-07-16 Bayer Ag, 5090 Leverkusen Isolierung und reinigung von aminoglycosid-antibiotiaka
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
WO2009117036A2 (en) * 2007-12-21 2009-09-24 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
WO2018005964A1 (en) * 2016-07-01 2018-01-04 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same
US10766970B2 (en) 2016-07-01 2020-09-08 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
DE1593321A1 (de) * 1962-04-03 1970-04-02 Rit Rech Ind Therapeut Verfahren zur Herstellung von niederen N-Alkylderivaten basischer Antibiotica

Also Published As

Publication number Publication date
SU659092A3 (en) 1979-04-25
LU76829A1 (el) 1978-10-18
DE2708008C3 (de) 1982-04-22
PT66229A (en) 1977-03-01
AR215616A1 (es) 1979-10-31
JPS52111545A (en) 1977-09-19
ES456304A1 (es) 1978-01-16
FR2351109B1 (el) 1981-07-24
EG12650A (en) 1979-06-30
FI770568A (el) 1977-08-26
FR2351127A1 (fr) 1977-12-09
ATA116777A (de) 1978-06-15
SE7702066L (sv) 1977-08-26
IE44885L (en) 1977-08-25
AT348123B (de) 1979-01-25
DE2708008B2 (de) 1981-07-02
GB1529243A (en) 1978-10-18
BE851777A (fr) 1977-08-24
US4107435A (en) 1978-08-15
HU179565B (en) 1982-11-29
FR2351109A1 (fr) 1977-12-09
DD135200A5 (de) 1979-04-18
DK82177A (da) 1977-08-26
CH618706A5 (el) 1980-08-15
IE44885B1 (en) 1982-05-05
CA1071624A (en) 1980-02-12
NL166265C (nl) 1981-07-15
DD130150A5 (de) 1978-03-08
FR2351127B1 (el) 1981-06-12
GR66424B (el) 1981-03-20
NL7901693A (nl) 1979-07-31
NL7701980A (nl) 1977-08-29
PL102193B1 (pl) 1979-03-31
DE2708008A1 (de) 1977-09-01
CS195715B2 (en) 1980-02-29
RO76081A (ro) 1981-08-17
PL103737B1 (pl) 1979-07-31
NL166265B (nl) 1981-02-16
PT66229B (en) 1978-07-17

Similar Documents

Publication Publication Date Title
CS195714B2 (en) Method of producing antimicrobially active derivatives of amoniglycoside
US4117221A (en) Aminoacyl derivatives of aminoglycoside antibiotics
US4424343A (en) Preparation of 1-N- ω-amino-α-hydroxyalkanoyl!kanamycin polysilylates and products
CA1083568A (en) Process for the preparation of aminoglycoside antibiotics and novel intermediates therefor
JPS6055520B2 (ja) リビドマイシンｂ誘導体の製法
IE47150B1 (en) Process for the preparation of antibacterial agents
US4547492A (en) 1-N-(ω-Amino-α-hydroxyalkanoyl-2',3'-dideoxykanamycin A and pharmaceutical composition containing same
EP0040764B1 (en) Novel aminoglycosides, and antibiotic use thereof
JPS5936914B2 (ja) セフアロスポリン類縁体
US4160082A (en) Intermediates for aminoglycoside antibiotics
SU965359A3 (ru) Способ получени 1N-( @ -окси- @ -аминоалканоил)-6N-метил-3,4-дидеоксиканамицина В
IE47709B1 (en) A process for the production of 4-aminobutyric acid or its derivatives
Fukase et al. A new method for the 3′-deoxygenation of butirosins A and B
US4268664A (en) Process for the preparation of 1-N-isoseryl- or 1-N-(L-4-amino-2-hydroxybutyryl)-3',4'-dideoxykanamycin B and intermediates thereof
IE45912B1 (en) New processes for the production of 3', 4'-dideoxykanamycin b
KR820000144B1 (ko) 아미노글리코사이드 유도체의 제조방법
CA1046057A (en) 1-N-(.alpha.-HYDROXY-.beta.-AMINOPROPIONYL) XK-62-2 AND METHOD OF PRODUCTION THEREOF
KR890002557B1 (ko) 아미노글리코사이드 계 항생물질 유도체의 제조방법
CS202571B2 (cs) Způsob výroby selektivně chráněného derivátu kanamycinu A nebo kanamycinu B
CN115772192A (zh) 一种磷霉素氨丁三醇ep杂质c的制备方法
JPS6043356B2 (ja) 耐性菌に有効なカナマイシンｃ誘導体およびそれらの製造法
CA1152063A (en) 3',4'-DIDEOXYKANAMYCIN A AND 1-N-((S)-.alpha.- HYDROXY-.omega.-AMINOALKANOLY) DERIVATIVES THEREOF
JPS631955B2 (el)
KR820000825B1 (ko) 1-n-알킬-치환된 카나마이신 유도체의 제조방법
KR810001691B1 (ko) 아미노낙산 유도체의 제조법